• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TACTICATH¿ CONTACT FORCE ABLATION CATHETER, SENSOR ENABLED¿ BID CURVE F-J; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TACTICATH¿ CONTACT FORCE ABLATION CATHETER, SENSOR ENABLED¿ BID CURVE F-J; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Model Number A-TCSE-DF
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Cardiac Perforation (2513)
Date of Event 01/21/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The product's lot number could not be obtained, therefore the primary di number is provided (d4), but full udi information is not available.
 
Event or Problem Description
During an atrial fibrillation pvi procedure in ensite x voxel mode, a pericardial effusion occurred which required a pericardiocentesis.Two transseptal punctures were performed as per standard for this procedure and while mapping the left atrium with the ablation catheter and an advisor fl mapping catheter, low blood pressure was observed.Transesophageal echocardiogram revealed a pericardial effusion.A pericardiocentesis was performed to stabilize the patient.There were no performance issues with any abbott device.
 
Event or Problem Description
This report includes updated device batch/lot number, model, and associated manufacturing information.
 
Additional Manufacturer Narrative
Additional information: b5, d4, d9, g3, h2, h3, h4, h6, h11.The results of the investigation are inconclusive since the device was not returned for analysis; however, the log files from the tactisys quartz system were returned.The log file analysis concluded that the tacticath se catheter performed as intended.The optical fibers met specifications and contact force measurements were displayed throughout the duration of the log files.The batch record was reviewed to ensure that each manufacturing and inspection operation was performed.The cause of the reported event remains unknown.Per the ifu, cardiac tamponade and pericardial effusion are known risks during the use of this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACTICATH¿ CONTACT FORCE ABLATION CATHETER, SENSOR ENABLED¿ BID CURVE F-J
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
ABBOTT MEDICAL
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 1897- 4050
CS  1897-4050
Manufacturer (Section G)
ABBOTT MEDICAL
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 1897- 4050
CS   1897-4050
Manufacturer Contact
wendy mccarty
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key24359233
Report Number3008452825-2026-00062
Device Sequence Number9887791
Product Code OAE
UDI-Device Identifier05415067027641
UDI-Public(01)05415067027641(10)10851512(17)261031
Combination Product (Y/N)N
Initial Reporter CountryGM
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/18/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberA-TCSE-DF
Device Catalogue NumberA-TCSE-DF
Device Lot Number10851512
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/21/2026
Supplement Date Received by Manufacturer02/22/2026
Initial Report FDA Received Date02/16/2026
Supplement Report FDA Received Date03/18/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/06/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Life Threatening;
Patient SexUnknown
-
-